₹2,261.00
₹-26.20 (-1.15%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹2,536 Cr
P/E
54.80
ROE
16.95%
ROCE
17.46%
About Beta Drugs Ltd
Beta Drugs manufacturing, and marketing of oncology (anti-cancer) products including tablets, capsules, and injections
Founded
2005
CEO
Rahul Batra
Employees
399
HQ
Baddi, Himachal Pradesh
About Beta Drugs Ltd
Beta Drugs manufacturing, and marketing of oncology (anti-cancer) products including tablets, capsules, and injections
Founded:2005
CEO:Rahul Batra
Employees:399
HQ:Baddi, Himachal Pradesh
Finished Products
1Sale of Products
₹417.82CrRaw Materials
1Cost of Materials Consumed
₹242.78CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹2,808
52W Low
₹990
Volume18.30K
Avg VolumeN/A
Beta0.92
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
54.80x
Valuation
P/B Ratio
10.32x
Valuation
EPS
₹41.74
Valuation
Dividend Yield
0.00%
Valuation
ROE
16.95%
Profitability
ROCE
17.46%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacturing of Oncology MedicinesRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
100.0%
Domestic Sales78.1%
Export Sales21.9%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.60x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
16.9%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.